Bain Capital Investors LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Bain Capital Investors LLC reported 5 stock positions worth $3.8 billion. Its top holding was Surgery Partners (SGRY) at 42.1% of the portfolio, followed by Nutanix Class A (NTNX, 26.1%) and Waystar (WAY, 20.4%). Compared with Q2 2024, it opened 1 new position and sold out of 1. The biggest buy was a new position in Nutanix Class A (NTNX) and the biggest sale an exit from Cerevel Therapeutics (CERE).
- Most Recent 13F
- Q2 2026
- Location
- Boston, MA
- CIK
- 0001040508
- Portfolio Value
- $3.8B (Q3 2024)
- SEC Filing
- 0000950123-24-011451 ↗ filed Nov 14, 2024
Holdings Value
Holdings 5 stocks · $3.8B
| SGRY Surgery Partners Inc. | 42.12% | 49,946,972 | $1.6B | No change |
| NTNX Nutanix Inc. Class A | 26.12% | 16,854,032 | $998.6M | New |
| WAY Waystar Holding Corp. | 20.41% | 27,980,417 | $780.4M | No change |
| AVAH Aveanna Healthcare Holdings | 11.10% | 81,600,880 | $424.3M | No change |
| ADV Advantage Solutions Inc. | 0.26% | 2,890,000 | $9.9M | No change |
Portfolio Sells Q2 2024 → Q3 2024
| CERE Cerevel Therapeutics Holding | Sold out | 0.00% | −57.02 |
Portfolio Buys Q2 2024 → Q3 2024
| NTNX Nutanix Inc. Class A | New | 26.12% | +26.12 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 8 | $4.8B | BOBS, SGRY, AVAH, KMTS, KLRA |
| Q1 2026 | 7 | $3.3B | BOBS, SGRY, AVAH, KMTS, WAY |
| Q4 2025 | 7 | $4.6B | COHR, SGRY, KMTS, AVAH, WAY |
| Q3 2025 | 6 | $3.4B | SGRY, AVAH, KMTS, WAY, NTNX |
| Q2 2025 | 6 | $3.1B | SGRY, WAY, KMTS, AVAH, NTNX |
| Q1 2025 | 6 | $3.9B | SGRY, WAY, NTNX, KMTS, AVAH |
| Q4 2024 | 5 | $3.5B | SGRY, NTNX, WAY, AVAH, ADV |
| Q3 2024 | 5 | $3.8B | SGRY, NTNX, WAY, AVAH, ADV |
| Q2 2024 | 5 | $4.7B | CERE, SGRY, WAY, AVAH, ADV |
| Q1 2024 | 4 | $4.5B | CERE, SGRY, AVAH, ADV |